Anabella Villalobos
Förmögenhet: 45 600 $ per 2026-08-31
Förmögenhet: 45 600 $ per 2026-08-31
Anabella Villalobos currently works at Coya Therapeutics, Inc., as Independent Director from 2021.
Dr. Villalobos also formerly worked at Biogen, Inc., as SVP-Biotherapeutics & Medicinal Sciences from 2017 to 2025 and Pfizer Inc., as Vice President from 1989 to 2017.
Dr. Villalobos received her doctorate degree from the University of Kansas and undergraduate degree from the University of Panama.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
COYA THERAPEUTICS, INC. 0,04 % | 2026-05-01 | 10 000 ( 0,04 % ) | 45 600 $ | 2026-08-31 |
| Företag | Position | Start |
|---|---|---|
| COYA THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2021-05-25 |
| Företag | Position | Slut |
|---|---|---|
| BIOGEN INC. | Företagsledare/Principal | 2025-01-01 |
| PFIZER INC. | Företagsledare/Principal | 2017-01-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Panama
University of Panama Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coya Therapeutics, Inc.
Coya Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that focuses on research and development of therapies to enhance the function of regulatory T cells | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån